Clinical Trial Update: Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in Russia [Phase 4]

View source ↗

Summary

Phase 4 trial assessing safety of co-administration of GSK Poliorix and Infanrix in healthy children in Russia; completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Infanrix (Diphtheria, Tetanus, and Acellular Pertussis Vaccine)
• Poliorix (inactivated poliovirus vaccine (IPV))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Poliomyelitis | Phase 4 | Status: COMPLETED | Results posted: 2013-12-30